Concepts (310)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Malaria | 49 | 2023 | 1226 | 8.280 |
Why?
|
Nigeria | 74 | 2024 | 762 | 5.120 |
Why?
|
Antimalarials | 32 | 2022 | 906 | 4.960 |
Why?
|
Artemisinins | 15 | 2020 | 218 | 2.130 |
Why?
|
Diagnostic Tests, Routine | 15 | 2022 | 786 | 1.800 |
Why?
|
Pregnancy Complications, Parasitic | 5 | 2022 | 61 | 1.520 |
Why?
|
Rural Population | 13 | 2021 | 2268 | 1.140 |
Why?
|
Health Knowledge, Attitudes, Practice | 14 | 2021 | 3986 | 1.120 |
Why?
|
Health Personnel | 12 | 2022 | 3310 | 1.100 |
Why?
|
Prenatal Care | 7 | 2022 | 1129 | 0.910 |
Why?
|
Parasitemia | 6 | 2022 | 166 | 0.880 |
Why?
|
Mothers | 7 | 2021 | 2186 | 0.820 |
Why?
|
Urban Population | 4 | 2020 | 2022 | 0.820 |
Why?
|
Fever | 9 | 2022 | 1617 | 0.800 |
Why?
|
Operations Research | 2 | 2018 | 22 | 0.780 |
Why?
|
Health Education | 5 | 2011 | 1049 | 0.760 |
Why?
|
Drug Combinations | 8 | 2020 | 2025 | 0.760 |
Why?
|
Laboratories, Hospital | 1 | 2022 | 193 | 0.710 |
Why?
|
Cross-Sectional Studies | 37 | 2023 | 25942 | 0.710 |
Why?
|
Insecticide-Treated Bednets | 5 | 2022 | 68 | 0.700 |
Why?
|
Ethanolamines | 3 | 2008 | 154 | 0.680 |
Why?
|
Prediabetic State | 2 | 2023 | 550 | 0.670 |
Why?
|
Nonprescription Drugs | 1 | 2020 | 118 | 0.660 |
Why?
|
Fluorenes | 3 | 2008 | 156 | 0.640 |
Why?
|
Needs Assessment | 3 | 2021 | 1139 | 0.630 |
Why?
|
Pharmacies | 1 | 2020 | 164 | 0.620 |
Why?
|
Home Nursing | 2 | 2008 | 92 | 0.600 |
Why?
|
Dental Health Surveys | 1 | 2017 | 39 | 0.600 |
Why?
|
Communicable Disease Control | 3 | 2021 | 844 | 0.600 |
Why?
|
Amodiaquine | 4 | 2019 | 58 | 0.590 |
Why?
|
Case Management | 6 | 2021 | 272 | 0.590 |
Why?
|
Tooth Diseases | 1 | 2017 | 74 | 0.580 |
Why?
|
Transients and Migrants | 1 | 2020 | 162 | 0.580 |
Why?
|
Laboratories | 3 | 2019 | 462 | 0.560 |
Why?
|
Perception | 2 | 2021 | 1195 | 0.550 |
Why?
|
Tuberculosis, Pulmonary | 1 | 2022 | 831 | 0.500 |
Why?
|
Patient Acceptance of Health Care | 5 | 2020 | 3164 | 0.490 |
Why?
|
Uganda | 12 | 2024 | 1324 | 0.480 |
Why?
|
Hypertension | 5 | 2023 | 8594 | 0.470 |
Why?
|
Clinical Protocols | 1 | 2020 | 1440 | 0.460 |
Why?
|
Caregivers | 8 | 2020 | 2224 | 0.450 |
Why?
|
Epidemics | 1 | 2019 | 510 | 0.440 |
Why?
|
Sulfadoxine | 3 | 2019 | 46 | 0.420 |
Why?
|
Preventive Health Services | 1 | 2017 | 570 | 0.420 |
Why?
|
Primary Prevention | 1 | 2020 | 1207 | 0.410 |
Why?
|
Pyrimethamine | 3 | 2019 | 94 | 0.410 |
Why?
|
Hospitals, Teaching | 1 | 2017 | 1166 | 0.400 |
Why?
|
Oral Health | 1 | 2017 | 486 | 0.400 |
Why?
|
Adult | 53 | 2024 | 219994 | 0.400 |
Why?
|
Patients | 1 | 2017 | 906 | 0.360 |
Why?
|
Female | 70 | 2024 | 391270 | 0.350 |
Why?
|
Burkina Faso | 7 | 2016 | 86 | 0.350 |
Why?
|
Health Services Research | 4 | 2021 | 1810 | 0.350 |
Why?
|
Medication Adherence | 2 | 2019 | 2165 | 0.330 |
Why?
|
Research Design | 2 | 2023 | 6180 | 0.330 |
Why?
|
Health Facilities | 6 | 2020 | 578 | 0.330 |
Why?
|
Research | 1 | 2017 | 1974 | 0.320 |
Why?
|
Child, Preschool | 23 | 2023 | 42063 | 0.320 |
Why?
|
Humans | 90 | 2024 | 760621 | 0.320 |
Why?
|
Breast Diseases | 2 | 2024 | 443 | 0.300 |
Why?
|
Audiovisual Aids | 1 | 2008 | 99 | 0.300 |
Why?
|
Prevalence | 12 | 2023 | 15687 | 0.300 |
Why?
|
Male | 55 | 2023 | 359744 | 0.290 |
Why?
|
Young Adult | 29 | 2024 | 58741 | 0.290 |
Why?
|
Delivery of Health Care | 4 | 2022 | 5325 | 0.280 |
Why?
|
Community-Based Participatory Research | 1 | 2008 | 226 | 0.270 |
Why?
|
Residence Characteristics | 1 | 2016 | 2062 | 0.270 |
Why?
|
Appointments and Schedules | 2 | 2019 | 442 | 0.270 |
Why?
|
Immunization Programs | 2 | 2021 | 268 | 0.270 |
Why?
|
Middle Aged | 36 | 2024 | 220352 | 0.270 |
Why?
|
Drug Prescriptions | 4 | 2020 | 1673 | 0.260 |
Why?
|
Practice Guidelines as Topic | 4 | 2020 | 7475 | 0.250 |
Why?
|
Infant | 17 | 2023 | 36060 | 0.240 |
Why?
|
Africa South of the Sahara | 7 | 2020 | 742 | 0.240 |
Why?
|
Program Development | 3 | 2021 | 1297 | 0.240 |
Why?
|
Kidney Failure, Chronic | 1 | 2017 | 2471 | 0.240 |
Why?
|
Echinococcus granulosus | 1 | 2023 | 11 | 0.230 |
Why?
|
Laboratory Personnel | 2 | 2022 | 19 | 0.230 |
Why?
|
Echinococcosis | 1 | 2023 | 31 | 0.230 |
Why?
|
Mosquito Control | 3 | 2022 | 106 | 0.220 |
Why?
|
Pregnancy Complications, Infectious | 2 | 2016 | 2125 | 0.220 |
Why?
|
Local Government | 2 | 2021 | 80 | 0.220 |
Why?
|
Chloroquine | 4 | 2008 | 277 | 0.210 |
Why?
|
Microbiological Techniques | 2 | 2020 | 98 | 0.200 |
Why?
|
Microscopy | 4 | 2018 | 885 | 0.200 |
Why?
|
Sputum | 2 | 2022 | 503 | 0.200 |
Why?
|
Drug Therapy, Combination | 4 | 2020 | 6498 | 0.200 |
Why?
|
Malaria, Falciparum | 2 | 2023 | 1076 | 0.200 |
Why?
|
Socioeconomic Factors | 7 | 2020 | 7806 | 0.190 |
Why?
|
Program Evaluation | 2 | 2021 | 2493 | 0.190 |
Why?
|
Pregnancy | 12 | 2022 | 29749 | 0.190 |
Why?
|
Tetanus Toxoid | 1 | 2021 | 193 | 0.190 |
Why?
|
Patient Compliance | 5 | 2019 | 2688 | 0.190 |
Why?
|
Focus Groups | 5 | 2019 | 1378 | 0.180 |
Why?
|
Epidemiology | 2 | 2014 | 278 | 0.180 |
Why?
|
Guideline Adherence | 3 | 2020 | 2283 | 0.180 |
Why?
|
Cities | 1 | 2023 | 538 | 0.180 |
Why?
|
HIV Infections | 3 | 2022 | 17165 | 0.180 |
Why?
|
Overweight | 3 | 2022 | 2421 | 0.180 |
Why?
|
Logistic Models | 7 | 2019 | 13314 | 0.170 |
Why?
|
Ambulatory Care Facilities | 2 | 2019 | 926 | 0.170 |
Why?
|
Child | 15 | 2023 | 79806 | 0.170 |
Why?
|
Employee Performance Appraisal | 1 | 2020 | 86 | 0.170 |
Why?
|
Immunization | 2 | 2021 | 1227 | 0.170 |
Why?
|
Attitude to Health | 1 | 2008 | 2029 | 0.160 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2023 | 12293 | 0.160 |
Why?
|
Reagent Kits, Diagnostic | 1 | 2019 | 238 | 0.150 |
Why?
|
DMF Index | 1 | 2017 | 87 | 0.150 |
Why?
|
Case-Control Studies | 5 | 2024 | 22053 | 0.150 |
Why?
|
Sentinel Surveillance | 1 | 2020 | 293 | 0.150 |
Why?
|
Tanzania | 3 | 2016 | 1383 | 0.150 |
Why?
|
Democratic Republic of the Congo | 1 | 2017 | 86 | 0.150 |
Why?
|
Public Health | 3 | 2017 | 2653 | 0.150 |
Why?
|
Inservice Training | 1 | 2020 | 375 | 0.140 |
Why?
|
Capacity Building | 1 | 2020 | 257 | 0.140 |
Why?
|
Drug Administration Schedule | 2 | 2019 | 4899 | 0.140 |
Why?
|
Knowledge | 1 | 2018 | 176 | 0.140 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 250 | 0.140 |
Why?
|
Personal Satisfaction | 1 | 2021 | 643 | 0.140 |
Why?
|
Obesity | 3 | 2023 | 12922 | 0.140 |
Why?
|
Accidents | 1 | 2017 | 166 | 0.140 |
Why?
|
Postnatal Care | 1 | 2019 | 260 | 0.140 |
Why?
|
Heart Failure | 1 | 2021 | 11847 | 0.130 |
Why?
|
Twins | 1 | 2018 | 339 | 0.130 |
Why?
|
Age Distribution | 3 | 2017 | 2893 | 0.130 |
Why?
|
Inappropriate Prescribing | 1 | 2018 | 209 | 0.130 |
Why?
|
Fast Foods | 1 | 2018 | 210 | 0.130 |
Why?
|
Reminder Systems | 1 | 2019 | 387 | 0.130 |
Why?
|
Adolescent | 15 | 2022 | 87810 | 0.130 |
Why?
|
Rural Health Services | 2 | 2009 | 381 | 0.120 |
Why?
|
Urbanization | 1 | 2015 | 100 | 0.120 |
Why?
|
Qualitative Research | 2 | 2020 | 2963 | 0.120 |
Why?
|
Risk Factors | 13 | 2024 | 74359 | 0.120 |
Why?
|
Anti-Infective Agents | 1 | 2022 | 981 | 0.120 |
Why?
|
Poultry | 1 | 2014 | 81 | 0.120 |
Why?
|
South Africa | 2 | 2016 | 1821 | 0.110 |
Why?
|
Outpatients | 1 | 2002 | 1607 | 0.110 |
Why?
|
Influenza in Birds | 1 | 2014 | 76 | 0.110 |
Why?
|
Clinical Laboratory Techniques | 1 | 2019 | 749 | 0.110 |
Why?
|
Blood Pressure | 2 | 2022 | 8525 | 0.110 |
Why?
|
Influenza A Virus, H5N1 Subtype | 1 | 2014 | 113 | 0.110 |
Why?
|
Maternal Health Services | 1 | 2019 | 455 | 0.110 |
Why?
|
Occupations | 1 | 2015 | 515 | 0.110 |
Why?
|
Administration, Rectal | 3 | 2016 | 70 | 0.110 |
Why?
|
Disease Outbreaks | 2 | 2020 | 1758 | 0.110 |
Why?
|
Counseling | 1 | 2020 | 1548 | 0.100 |
Why?
|
Epidemiologic Studies | 1 | 2015 | 670 | 0.100 |
Why?
|
Infant, Newborn | 6 | 2020 | 26181 | 0.100 |
Why?
|
Violence | 1 | 2017 | 927 | 0.090 |
Why?
|
Administration, Oral | 2 | 2016 | 4035 | 0.090 |
Why?
|
Mycobacterium tuberculosis | 1 | 2022 | 1903 | 0.090 |
Why?
|
Disease Transmission, Infectious | 1 | 2016 | 558 | 0.090 |
Why?
|
Antibodies, Viral | 1 | 2022 | 3143 | 0.090 |
Why?
|
Antitubercular Agents | 1 | 2019 | 1373 | 0.090 |
Why?
|
Occupational Exposure | 1 | 2020 | 1809 | 0.080 |
Why?
|
Refugees | 1 | 2017 | 598 | 0.080 |
Why?
|
Commerce | 1 | 2014 | 605 | 0.080 |
Why?
|
Directly Observed Therapy | 2 | 2019 | 139 | 0.080 |
Why?
|
Community Medicine | 1 | 2008 | 23 | 0.080 |
Why?
|
Interviews as Topic | 3 | 2014 | 2659 | 0.080 |
Why?
|
Awareness | 1 | 2013 | 646 | 0.080 |
Why?
|
Chemoprevention | 1 | 2011 | 326 | 0.080 |
Why?
|
Sepsis | 1 | 2022 | 2592 | 0.080 |
Why?
|
Attitude of Health Personnel | 2 | 2019 | 3865 | 0.080 |
Why?
|
Vaccines | 1 | 2016 | 832 | 0.070 |
Why?
|
Insurance, Health | 1 | 2020 | 2501 | 0.070 |
Why?
|
Morphine | 1 | 2012 | 655 | 0.070 |
Why?
|
Health Expenditures | 1 | 2020 | 2362 | 0.070 |
Why?
|
Sensitivity and Specificity | 4 | 2023 | 14660 | 0.070 |
Why?
|
Educational Status | 2 | 2017 | 2515 | 0.070 |
Why?
|
Feasibility Studies | 2 | 2008 | 5201 | 0.070 |
Why?
|
Family Characteristics | 3 | 2018 | 1001 | 0.070 |
Why?
|
Cardiovascular Diseases | 2 | 2023 | 15757 | 0.070 |
Why?
|
Time Factors | 5 | 2020 | 40165 | 0.070 |
Why?
|
Referral and Consultation | 2 | 2016 | 3598 | 0.070 |
Why?
|
Ghana | 1 | 2008 | 312 | 0.070 |
Why?
|
Child Development | 1 | 2018 | 2285 | 0.070 |
Why?
|
Blood | 1 | 2008 | 586 | 0.070 |
Why?
|
Selection, Genetic | 2 | 2007 | 869 | 0.070 |
Why?
|
Government Programs | 1 | 2008 | 280 | 0.070 |
Why?
|
Hospitals | 1 | 2019 | 3928 | 0.070 |
Why?
|
Tuberculosis | 1 | 2019 | 2001 | 0.060 |
Why?
|
Feeding Behavior | 1 | 2018 | 3185 | 0.060 |
Why?
|
Exercise | 1 | 2022 | 5787 | 0.060 |
Why?
|
Geography | 3 | 2014 | 661 | 0.060 |
Why?
|
Wounds and Injuries | 1 | 2017 | 2477 | 0.060 |
Why?
|
Alcohol Drinking | 1 | 2017 | 4013 | 0.060 |
Why?
|
Chi-Square Distribution | 2 | 2020 | 3465 | 0.060 |
Why?
|
Interview, Psychological | 1 | 2008 | 810 | 0.060 |
Why?
|
Pregnancy Complications | 1 | 2018 | 2942 | 0.060 |
Why?
|
HIV-1 | 1 | 2022 | 6849 | 0.060 |
Why?
|
Haplotypes | 2 | 2007 | 2764 | 0.060 |
Why?
|
Mass Screening | 1 | 2020 | 5423 | 0.060 |
Why?
|
Vaccination | 1 | 2016 | 3361 | 0.060 |
Why?
|
Cameroon | 1 | 2024 | 74 | 0.060 |
Why?
|
Health Services Accessibility | 4 | 2020 | 5397 | 0.060 |
Why?
|
Antibodies, Helminth | 1 | 2023 | 57 | 0.060 |
Why?
|
Body Mass Index | 2 | 2023 | 12914 | 0.060 |
Why?
|
Cultural Characteristics | 1 | 2005 | 253 | 0.050 |
Why?
|
Health Surveys | 3 | 2019 | 4063 | 0.050 |
Why?
|
Pilot Projects | 3 | 2017 | 8555 | 0.050 |
Why?
|
Seroepidemiologic Studies | 1 | 2023 | 394 | 0.050 |
Why?
|
Mammography | 1 | 2013 | 2427 | 0.050 |
Why?
|
Breast Neoplasms | 2 | 2024 | 21025 | 0.050 |
Why?
|
Proteins | 1 | 2016 | 6029 | 0.050 |
Why?
|
Developing Countries | 3 | 2020 | 2868 | 0.050 |
Why?
|
Universal Precautions | 1 | 2020 | 34 | 0.040 |
Why?
|
Obesity, Abdominal | 1 | 2023 | 374 | 0.040 |
Why?
|
Chronic Disease | 1 | 2015 | 9287 | 0.040 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2002 | 389 | 0.040 |
Why?
|
Needlestick Injuries | 1 | 2020 | 71 | 0.040 |
Why?
|
Diet | 1 | 2018 | 8010 | 0.040 |
Why?
|
Disease Notification | 1 | 2020 | 97 | 0.040 |
Why?
|
Polymerase Chain Reaction | 1 | 2008 | 6068 | 0.040 |
Why?
|
Dogs | 1 | 2023 | 3841 | 0.040 |
Why?
|
Cohort Studies | 3 | 2023 | 41335 | 0.040 |
Why?
|
Primary Health Care | 2 | 2019 | 4647 | 0.040 |
Why?
|
Palpation | 1 | 2018 | 166 | 0.040 |
Why?
|
Body Fluids | 1 | 2020 | 319 | 0.040 |
Why?
|
Aged | 7 | 2024 | 169152 | 0.040 |
Why?
|
Palliative Care | 1 | 2013 | 3607 | 0.040 |
Why?
|
Hospital Mortality | 1 | 2012 | 5425 | 0.040 |
Why?
|
Contact Tracing | 1 | 2020 | 268 | 0.040 |
Why?
|
Pregnancy Trimesters | 1 | 2019 | 197 | 0.040 |
Why?
|
Diabetes Mellitus | 1 | 2016 | 5889 | 0.040 |
Why?
|
Follow-Up Studies | 3 | 2018 | 39261 | 0.040 |
Why?
|
Poliovirus Vaccine, Oral | 1 | 2016 | 26 | 0.030 |
Why?
|
Ethiopia | 1 | 2019 | 462 | 0.030 |
Why?
|
Pain | 1 | 2012 | 5066 | 0.030 |
Why?
|
Ultrasonography, Mammary | 1 | 2018 | 239 | 0.030 |
Why?
|
Confidence Intervals | 1 | 2002 | 2932 | 0.030 |
Why?
|
Estradiol | 1 | 2023 | 1932 | 0.030 |
Why?
|
Measles Vaccine | 1 | 2016 | 81 | 0.030 |
Why?
|
False Positive Reactions | 1 | 2018 | 956 | 0.030 |
Why?
|
Pregnancy Trimester, Third | 1 | 2018 | 582 | 0.030 |
Why?
|
Analgesics, Opioid | 1 | 2012 | 3763 | 0.030 |
Why?
|
Cluster Analysis | 1 | 2022 | 2698 | 0.030 |
Why?
|
Prehypertension | 1 | 2015 | 63 | 0.030 |
Why?
|
Education, Veterinary | 1 | 2014 | 7 | 0.030 |
Why?
|
Public Sector | 1 | 2016 | 265 | 0.030 |
Why?
|
Treatment Outcome | 3 | 2019 | 65017 | 0.030 |
Why?
|
Rural Health | 1 | 2016 | 296 | 0.030 |
Why?
|
Genome, Human | 1 | 2007 | 4417 | 0.030 |
Why?
|
Postmenopause | 1 | 2023 | 2509 | 0.030 |
Why?
|
Disease Reservoirs | 1 | 2014 | 121 | 0.030 |
Why?
|
Government Agencies | 1 | 2014 | 160 | 0.030 |
Why?
|
Population Surveillance | 2 | 2014 | 2608 | 0.030 |
Why?
|
Plasmodium falciparum | 1 | 2023 | 1742 | 0.030 |
Why?
|
Urban Health | 1 | 2016 | 533 | 0.030 |
Why?
|
Breast Self-Examination | 1 | 2013 | 33 | 0.030 |
Why?
|
Private Sector | 1 | 2016 | 397 | 0.030 |
Why?
|
Education, Professional | 1 | 2013 | 51 | 0.030 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2020 | 1348 | 0.030 |
Why?
|
Communications Media | 1 | 2013 | 42 | 0.030 |
Why?
|
Community Networks | 1 | 2014 | 201 | 0.030 |
Why?
|
Physical Examination | 1 | 2018 | 1244 | 0.030 |
Why?
|
Students | 1 | 2022 | 1730 | 0.030 |
Why?
|
Drug Resistance | 1 | 2018 | 1617 | 0.030 |
Why?
|
Postpartum Period | 1 | 2018 | 1167 | 0.020 |
Why?
|
Pregnant Women | 1 | 2016 | 563 | 0.020 |
Why?
|
Health Priorities | 1 | 2014 | 374 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2007 | 15789 | 0.020 |
Why?
|
Bacteria | 1 | 2022 | 2199 | 0.020 |
Why?
|
Africa | 1 | 2013 | 705 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2018 | 15289 | 0.020 |
Why?
|
Sex Distribution | 1 | 2015 | 2295 | 0.020 |
Why?
|
Animals | 4 | 2023 | 167963 | 0.020 |
Why?
|
Patient Satisfaction | 1 | 2002 | 3448 | 0.020 |
Why?
|
Specimen Handling | 1 | 2014 | 707 | 0.020 |
Why?
|
Breast | 1 | 2018 | 1963 | 0.020 |
Why?
|
Congresses as Topic | 1 | 2014 | 805 | 0.020 |
Why?
|
Goals | 1 | 2014 | 708 | 0.020 |
Why?
|
Retrospective Studies | 1 | 2017 | 80372 | 0.020 |
Why?
|
Edar Receptor | 1 | 2007 | 24 | 0.020 |
Why?
|
Teaching | 1 | 2015 | 1169 | 0.020 |
Why?
|
International Cooperation | 1 | 2014 | 1433 | 0.020 |
Why?
|
Quality Improvement | 1 | 2022 | 3836 | 0.020 |
Why?
|
Prospective Studies | 3 | 2019 | 54303 | 0.020 |
Why?
|
Motivation | 1 | 2016 | 1993 | 0.020 |
Why?
|
Antiporters | 1 | 2007 | 278 | 0.020 |
Why?
|
Odds Ratio | 1 | 2018 | 9716 | 0.020 |
Why?
|
Nurses | 1 | 2015 | 2467 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2022 | 15840 | 0.010 |
Why?
|
Self Administration | 1 | 2005 | 390 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2022 | 7408 | 0.010 |
Why?
|
Health Behavior | 1 | 2015 | 2622 | 0.010 |
Why?
|
Recombination, Genetic | 1 | 2007 | 1526 | 0.010 |
Why?
|
Homozygote | 1 | 2007 | 1788 | 0.010 |
Why?
|
Neoplasms | 1 | 2012 | 22072 | 0.010 |
Why?
|
Genetics, Population | 1 | 2007 | 930 | 0.010 |
Why?
|
Linkage Disequilibrium | 1 | 2007 | 1996 | 0.010 |
Why?
|
Family | 1 | 2013 | 3189 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2018 | 14495 | 0.010 |
Why?
|
Age Factors | 1 | 2019 | 18416 | 0.010 |
Why?
|
Fathers | 1 | 2005 | 376 | 0.010 |
Why?
|
Pain Measurement | 1 | 2012 | 3528 | 0.010 |
Why?
|
Communication Barriers | 1 | 2005 | 415 | 0.010 |
Why?
|
Cause of Death | 1 | 2012 | 3725 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2018 | 10344 | 0.010 |
Why?
|
Mental Health | 1 | 2015 | 3213 | 0.010 |
Why?
|
Health Promotion | 1 | 2013 | 2206 | 0.010 |
Why?
|
Gene Frequency | 1 | 2007 | 3615 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2007 | 3800 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2018 | 20080 | 0.010 |
Why?
|
Causality | 1 | 2005 | 1242 | 0.010 |
Why?
|
Models, Molecular | 1 | 2007 | 5434 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2013 | 58995 | 0.010 |
Why?
|
Data Collection | 1 | 2005 | 3315 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2013 | 17790 | 0.010 |
Why?
|
United States | 1 | 2014 | 72461 | 0.000 |
Why?
|
Concepts
(310)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(25)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_